1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Chile Pharmaceuticals and Healthcare Report Q4 2016

Chile Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 95 pages

Includes 3 FREE quarterly updates


BMI View: Chile's healthcare reform and sector investment will continue to expand the role of the state in the provision of health services and medicines. The stable political and economic outlook in Chile provides a solid foundation for the government to launch assistance programmes such as the 'People's Pharmacy' to improve patients' access to innovative medicines. It will also boost volume sales for multinational drugmakers in Chile.

Headline Expenditure Projections
Pharmaceuticals: From CLP2.2trn (USD3.3bn) in 2015 to CLP2.4trn (USD3.5bn) in 2016; +8.6% in local currency terms and +5.3% in US dollar terms. Forecast unchanged from last quarter.
Healthcare: From CLP12.7trn (USD19.4bn) in 2015 to CLP14.0trn (USD20.7bn) in 2016; +10.1% rise in local currency terms and +6.8% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Chile Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Chile 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Chile 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Chile 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 24
OTC Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Chile 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Chile 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Chile 2014-2020) 29
Industry Risk Reward Index 30
Americas Risk/Reward Index 30
Chile Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 43
Pricing Regime 45
Public Procurement 46
Table: Pharmaceutical Price Build-Up (%) 46
Reimbursement Regime 46
Market Overview 48
Healthcare Sector 48
Table: Healthcare Resources (Chile 2009-2014) 53
Table: Healthcare Personnel (Chile 2009-2014) 53
Table: Healthcare Activity (2009-2014) 54
Research And Development 56
Clinical Trials 57
Epidemiology 58
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Market Activity 63
Pharmaceutical Distribution 64
Pharmaceutical Retail Sector 64
Company Profile 66
Corporación Farmaceutica Recalcine (CFR) 66
GlaxoSmithKline 69
Laboratorios Andrómaco 71
Laboratorios Chile (LabChile) 73
Merck and Co 76
Novartis 78
Pfizer 80
Sanofi 82
Demographic Forecast 84
Table: Population Headline Indicators (Chile 1990-2025) 85
Table: Key Population Ratios (Chile 1990-2025) 85
Table: Urban/Rural Population and Life Expectancy (Chile 1990-2025) 86
Table: Population By Age Group (Chile 1990-2025) 86
Table: Population By Age Group % (Chile 1990-2025) 87
Glossary 89
Methodology 91
Pharmaceutical Expenditure Forecast Model 91
Healthcare Expenditure Forecast Model 91
Notes On Methodology 92
Risk/Reward Index Methodology 93
Index Overview 94
Table: Pharmaceutical Risk/Reward Index Indicators 94
Indicator Weightings 95

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.